| Industrial interests versus public health: the gap is growing. | |
| | |
MedLine Citation:
|
PMID: 15148985 Owner: HSR Status: MEDLINE |
Abstract/OtherAbstract:
|
(1) Drug companies pretending to innovate; health authorities pretending to regulate; medicines agencies pretending to be transparent: the main players in the medicines roadshow had their hands full in 2003, with little time for patients and their daily concerns. (2) On a more optimistic note, 2003 also saw civil society contributing forcefully to the debate on the future European legislative framework on medicines. One result is that medicines agencies will have to be more transparent in future. |
| | |
Authors:
|
- |
Related Documents
:
|
16001325 - Multiple endocrine neoplasias in the era of translational medicine. 15034855 - Sports and performing arts medicine. 1. general considerations for sports and performin... 20054075 - Tying art and science to reality for recruiting minorities to veterinary medicine. 19380415 - Approaches to improve the diagnosis and management of infertility. 21851565 - Promoting clinical reasoning in general practice trainees: role of the clinical teacher. 10115725 - Whither, or wither nuclear medicine? |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Prescrire international Volume: 13 ISSN: 1167-7422 ISO Abbreviation: Prescrire Int Publication Date: 2004 Apr |
Date Detail:
|
Created Date: 2004-05-18 Completed Date: 2004-05-21 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9439295 Medline TA: Prescrire Int Country: France |
Other Details:
|
Languages: eng Pagination: 71-6 Citation Subset: T |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Conflict of Interest* Drug Industry* Drug Packaging Drugs, Generic Economic Competition Europe France Humans Legislation, Drug* Marketing Public Health* |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Atrial fibrillation: rate control often better than rhythm control.
Next Document: Prion protein and the molecular features of transmissible spongiform encephalopathy agents.